Detalhe da pesquisa
1.
The impact of preexisting psychiatric disorders and antidepressant use on COVID-19 related outcomes: a multicenter study.
Mol Psychiatry
; 28(6): 2462-2468, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37069343
2.
The Effect of Methylphenidate on Cognition in Patients with Comorbid Attention Deficit/Hyperactivity Disorder and Amphetamine Use Disorder: An Exploratory Single-Blinded within-Subject Study.
Eur Addict Res
; 30(1): 1-13, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38029734
3.
Racial differences in COVID-19 severity associated with history of substance use disorders and overdose: Findings from multi-site electronic health records in New York City.
Prev Med
; 172: 107533, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37146730
4.
Sublingual dexmedetomidine (BXCL501) reduces opioid withdrawal symptoms: findings from a multi-site, phase 1b/2, randomized, double-blind, placebo-controlled trial.
Am J Drug Alcohol Abuse
; 49(1): 109-122, 2023 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36630319
5.
Open label trial of lofexidine-assisted non-opioid induction onto naltrexone extended-release injection for opioid use disorder.
Am J Drug Alcohol Abuse
; 49(5): 618-629, 2023 09 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37791817
6.
The clinical course of comorbid substance use disorder and attention deficit/hyperactivity disorder: protocol and clinical characteristics of the INCAS study.
BMC Psychiatry
; 22(1): 625, 2022 09 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36151539
7.
Safety and tolerability of progesterone treatment for women with cocaine use disorder: a pilot treatment trial.
Am J Drug Alcohol Abuse
; 48(5): 586-595, 2022 09 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36095308
8.
New directions in the treatment of opioid withdrawal.
Lancet
; 395(10241): 1938-1948, 2020 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32563380
9.
Drinking reduction during cognitive behavioral therapy for alcohol use disorder is associated with a reduction in anterior insula-bed nucleus of the stria terminalis resting-state functional connectivity.
Alcohol Clin Exp Res
; 45(8): 1596-1606, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34342012
10.
Pilot randomized placebo-controlled clinical trial of high-dose gabapentin for alcohol use disorder.
Alcohol Clin Exp Res
; 45(8): 1639-1652, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34120336
11.
First-Year Trajectories of Medical Cannabis Use Among Adults Taking Opioids for Chronic Pain: An Observational Cohort Study.
Pain Med
; 22(12): 3080-3088, 2021 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34411246
12.
5HT-2C agonist lorcaserin decreases cannabis self-administration in daily cannabis smokers.
Addict Biol
; 26(4): e12993, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33389797
13.
Open-label trial of a single-day induction onto buprenorphine extended-release injection for users of heroin and fentanyl.
Am J Addict
; 30(5): 470-476, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34223681
14.
Ketamine-facilitated behavioral treatment for cannabis use disorder: A proof of concept study.
Am J Drug Alcohol Abuse
; 47(1): 92-97, 2021 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33175580
15.
Open-label pilot study of lisdexamfetamine for cocaine use disorder.
Am J Drug Alcohol Abuse
; 47(3): 402-409, 2021 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33797985
16.
An open-label pilot study of pregabalin pharmacotherapy for alcohol use disorder.
Am J Drug Alcohol Abuse
; 47(4): 467-475, 2021 07 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34092158
17.
Impulsive Personality Traits Mediate the Relationship Between Attention-Deficit/Hyperactivity Disorder Symptoms and Psychiatric Comorbidity among Patients with Severe Alcohol Use Disorder.
J Dual Diagn
; 17(3): 193-206, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34313557
18.
The utility of a formative one-station objective structured clinical examination for Substance use disorders in a dental curriculum.
Eur J Dent Educ
; 25(4): 813-828, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33471403
19.
[International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder]. / Internationale Konsenserklärung zu Screening, Diagnostik und Behandlung von Jugendlichen und Heranwachsenden mit Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung und gleichzeitigen Störungen durch Substanzgebrauch.
Z Kinder Jugendpsychiatr Psychother
; 50(1): 54-67, 2021 Jan.
Artigo
em Alemão
| MEDLINE | ID: mdl-34397296
20.
Case Series: Rapid Induction Onto Long Acting Buprenorphine Injection for High Potency Synthetic Opioid Users.
Am J Addict
; 29(4): 345-348, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32167629